glp-1 drugs india Did you know? is now the world's 2nd largest GLP‑1 market. With 2026 patent expiries ahead, a massive opportunity could open up in diabetes & obesity care #MarketTalks #EdelweissMutualFund GLP-1 Drugs Boom: India’s Next

This new technology allows the delivery of a wide array of ingredients to the systemic circulation by the intestinal lymphatic route, circumventing first-pass inactivation in the liver for the very first time

While not a complete solution to muscle loss, it offers some protective effect when combined with adequate dietary protein and resistance training

M.HansenS.HarringtonK

Chronic cadmium exposure induces hepatic dysfunction and gut microbiota dysbiosis in mice

After coming to UT MD Anderson, I began working with patients whose cancer treatment caused oral mucositis, inflammation in the gastrointestinal tract that can cause mouth sores and ulcers